DJIA 17,646.67 50.32 0.29%
NASDAQ 4,983.43 24.96 0.50%
S&P 500 2,062.39 4.75 0.23%
market minute promo

Sanofi (ADR) (NYSE: SNY)

49.73 -0.11 (-0.22%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SNY $49.73 -0.22%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.62
Previous Close $49.84
Daily Range $49.75 - $50.64
52-Week Range $43.57 - $57.42
Market Cap $131.2B
P/E Ratio 26.80
Dividend (Yield) $1.61 (2.2%)
Ex-Dividend Date
Dividend Pay Date
05/06/15
06/02/15
Volume 365,364
Average Daily Volume 1,896,789
Current FY EPS $3.23

Sector

Healthcare

Industry

Drug Makers

Sanofi (ADR) (SNY) Description

A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. Website: http://www.sanofi.com/

News & Commentary Rss Feed

Isis Pharmaceuticals Inc. Investors Can Finally Sense a Bright Future

After decades of zero return, Isis Pharmaceuticals' stock has been on fire recently. Is it smart to jump on board now?

Vertex Pharma: Well Positioned To Set New Highs

Are Cancer Drugs Becoming Too Costly for Their Effectiveness?

MannKind's Afrezza: Another Look At The Early Adopters

Regeneron's Growth Governed By 3 Key Prospects

The Revenue Challenge Ahead for Eli Lilly and Co

Eli Lilly has lost patent protection in recent years for several blockbuster drugs, with more losses on the way. Here are the details investors need to know.

Alnylam Reports Encouraging New Data on Hemophilia Drug - Analyst Blog

Pep Boys, Acacia Research, Sanofi, Unilever and Continental Aktiengesellschaft highlighted as Zacks

Pep Boys, Acacia Research, Sanofi, Unilever and Continental Aktiengesellschaft highlighted as Zacks Bull and Bear of the Day - Press Releases

Are These Heavily Shorted Biotech Stocks Good Contrarian Buys?

Short-sellers have piled into Adaptimmune Therapeutics and MannKind Corp. this year. Could these two biotechs represent good contrarian buys for the long-term investor?

European ADRs Flat Despite Health Care Stock Gains

See More SNY News...

SNY's Top Competitors

SNY $49.73 (-0.22%)
Current stock: SNY
JNJ $98.24 (0.57%)
Current stock: JNJ
MRK $57.21 (-0.14%)
Current stock: MRK
GSK $41.90 (-0.31%)
Current stock: GSK